Antonia M Calafat Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

10/2023	Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the Multiethnic Cohort Study.
1/2021	Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonia M Calafat Research Topics

Disease

18	Birth Weight (Birth Weights) 01/2024 - 08/2008
14	Obesity 05/2024 - 04/2016
14	Asthma (Bronchial Asthma) 02/2023 - 06/2012
13	Premature Birth (Birth, Premature) 12/2023 - 10/2009
10	Infertility (Sterility) 04/2024 - 12/2013
10	Breast Neoplasms (Breast Cancer) 11/2023 - 04/2010
10	Overweight 12/2021 - 01/2012
7	Neoplasms (Cancer) 11/2023 - 01/2018
7	Insulin Resistance 01/2023 - 01/2017
7	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2022 - 01/2015
6	Leiomyoma (Uterine Fibroids) 04/2024 - 01/2019
6	Pregnancy Complications 01/2024 - 06/2014
6	Autism Spectrum Disorder 01/2021 - 05/2014
6	Inflammation (Inflammations) 01/2021 - 11/2012
5	Gestational Weight Gain 05/2023 - 12/2019
5	Body Weight (Weight, Body) 01/2021 - 08/2011
3	Hypertension (High Blood Pressure) 04/2024 - 01/2020
3	Glucose Intolerance 01/2022 - 01/2018
3	Hypercholesterolemia 01/2021 - 01/2016
3	Respiratory Sounds (Crackle) 01/2018 - 12/2014
3	Pediatric Obesity 09/2017 - 11/2014
2	Esophageal Squamous Cell Carcinoma 03/2024 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 01/2021
2	Spontaneous Abortion (Miscarriage) 01/2023 - 03/2016
2	Pre-Eclampsia (Preeclampsia) 01/2022 - 02/2020
2	Carcinogenesis 12/2021 - 01/2018
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 01/2020
2	Hypersensitivity (Allergy) 07/2020 - 10/2012
2	Weight Gain 01/2020 - 12/2019
2	Intellectual Disability (Idiocy) 01/2019 - 01/2018
2	Muscle Hypotonia (Hypotonia) 03/2015 - 09/2013

Drug/Important Bio-Agent (IBA)

56	phthalic acid (phthalate)IBA 02/2024 - 08/2005
38	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2011
19	Endocrine DisruptorsIBA 05/2024 - 06/2012
17	FluorocarbonsIBA 04/2024 - 01/2018
16	PhenolsIBA 05/2024 - 03/2012
15	bisphenol AIBA 01/2021 - 06/2012
14	ParabensIBA 02/2024 - 08/2014
12	perfluorooctanoic acidIBA 12/2023 - 01/2015
11	Phenol (Carbolic Acid)FDA Link 01/2023 - 01/2018
10	Diethylhexyl Phthalate (DEHP)IBA 10/2022 - 10/2014
8	Triclosan (pHisoHex)FDA Link 01/2023 - 01/2017
7	ORALIT (ORS)IBA 03/2024 - 06/2010
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
6	LipidsIBA 01/2023 - 01/2017
5	monobutyl phthalateIBA 02/2024 - 10/2014
5	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2020
5	oxybenzone (Solbar)FDA Link 01/2023 - 08/2008
5	monoethyl phthalateIBA 10/2022 - 01/2012
5	CreatinineIBA 10/2021 - 09/2013
4	AntralIBA 04/2024 - 12/2013
4	perfluorooctane sulfonic acidIBA 01/2024 - 10/2017
4	hexadecafluoro-nonanoic acidIBA 12/2023 - 01/2016
4	perflexane (perfluorohexane)FDA Link 12/2023 - 01/2016
4	PesticidesIBA 02/2023 - 07/2012
4	propylparaben FDA LinkGeneric 01/2023 - 03/2016
4	methylparaben FDA LinkGeneric 01/2023 - 03/2016
4	2,5-dichlorophenolIBA 01/2023 - 08/2008
4	perfluorooctaneIBA 01/2022 - 01/2016
4	EstersIBA 01/2022 - 01/2019
3	Follicle Stimulating Hormone (Follitropin)FDA Link 04/2024 - 12/2013
3	Hormones (Hormone)IBA 11/2023 - 01/2020
3	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2023 - 01/2017
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2023 - 11/2012
3	2,4-dichlorophenolIBA 01/2023 - 03/2012
3	LDL CholesterolIBA 08/2022 - 01/2020
3	CholesterolIBA 08/2022 - 01/2016
3	LeptinIBA 01/2021 - 01/2017
3	OrganophosphatesIBA 11/2020 - 07/2012
3	PlasticizersIBA 01/2020 - 11/2015
3	InsecticidesIBA 12/2019 - 07/2012
3	Dibutyl Phthalate (Butyl Phthalate)IBA 01/2018 - 10/2014
3	butylbenzyl phthalate (benzyl butyl phthalate)IBA 11/2015 - 10/2012
3	mono-(2-ethylhexyl)phthalateIBA 01/2014 - 02/2010
2	CarcinogensIBA 10/2023 - 01/2021
2	Phosphates (Orthophosphate)IBA 01/2023 - 07/2012
2	Insulin (Novolin)FDA Link 01/2023 - 10/2021
2	butylparabenIBA 01/2023 - 03/2016
2	Complex MixturesIBA 10/2022 - 01/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 08/2022 - 10/2021
2	HDL LipoproteinsIBA 08/2022 - 10/2021
2	mono-isobutyl phthalateIBA 01/2022 - 11/2019
2	triclocarbanIBA 12/2021 - 01/2020
2	AdiponectinIBA 01/2021 - 01/2017
2	bis(4-hydroxyphenyl)sulfoneIBA 01/2021 - 01/2021
2	AdipokinesIBA 01/2021 - 12/2018
2	CosmeticsIBA 07/2020 - 12/2018
2	AcidsIBA 01/2020 - 01/2019
2	Permethrin (Ambush)FDA LinkGeneric 01/2019 - 12/2018
2	diethyl phthalateIBA 01/2018 - 10/2014
2	SmokeIBA 01/2018 - 01/2017
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 09/2017 - 10/2014
2	diisodecyl phthalateIBA 01/2017 - 02/2013
2	Mesalamine (Mesalazine)FDA LinkGeneric 10/2014 - 05/2004
1	N'-nitrosoanatabineIBA 03/2024
1	1,3-butadiene (divinyl)IBA 03/2024
1	Xylenes (Xylene)IBA 03/2024
1	propylene oxideIBA 03/2024
1	AcrylonitrileIBA 03/2024
1	Acrolein (Aqualin)IBA 03/2024